News: Pfizer Ltd (PFIZ.BO)

PFIZ.BO on Bombay Stock Exchange

942.55INR
3:04am EST
Price Change (% chg)

Rs-8.80 (-0.93%)
Prev Close
Rs951.35
Open
Rs963.85
Day's High
Rs963.85
Day's Low
Rs940.00
Volume
2,572
Avg. Vol
2,474
52-wk High
Rs1,000.00
52-wk Low
Rs450.15

view news for:
Select another date:

Fri, Oct 23 2009

Pfizer taps Indian drug cos for alliances-report

MUMBAI, Oct 23 (Reuters) - U.S. drug firm Pfizer has approached several Indian drugmakers for possible alliances to bolster its revenues, the Economic Times reported on Friday.

Continue Reading

Pfizer open offer for India unit to start June 10

MUMBAI, April 16 (Reuters) - An open offer by U.S. drugmaker Pfizer Inc to buy 33.77 percent in its Indian unit, Pfizer Ltd , will start on June 10 and close on June 29, the offer manager said on Thursday.

UPDATE 1-Pfizer offers to boost stake in Indian arm

NEW YORK, April 12 (Reuters) - U.S. drug maker Pfizer Inc offered on Sunday to pay about $136 million to boost its stake in its Indian arm Pfizer Ltd to 75 percent.

TABLE-Pfizer India quarterly net jumps on year

(versus the same period a year earlier, in million rupees unless stated)

TABLE-Pfizer India Q4 net up 30 pct year/year

(versus the same period a year earlier, in million rupees unless stated)

Pfizer says ruling favorable in NY Celebrex case

LOS ANGELES (Reuters) - U.S. drugmaker Pfizer Inc said on Wednesday a New York State court ruling related to litigation over the company's painkiller Celebrex may cause many cases to be dismissed.

UPDATE 1-Pfizer says ruling favorable in NY Celebrex case

LOS ANGELES, Jan 9 (Reuters) - U.S. drugmaker Pfizer Inc said on Wednesday a New York State court ruling related to litigation over the company's painkiller Celebrex may cause many cases to be dismissed.

Pfizer says ruling favorable in NY Celebrex case

LOS ANGELES, Jan 9 (Reuters) - U.S. drugmaker Pfizer Inc said on Wednesday a New York State court ruling related to litigation over the company's anti-inflammatory drug Celebrex may cause many cases to be dismissed.

Pfizer India to get $55 mln from licence transfer

MUMBAI, Dec 31 (Reuters) - Pfizer Ltd , the Indian unit of drug maker Pfizer Inc , said on Monday its board has approved transferring a licence to Johnson & Johnson Ltd for 2.15 billion rupees ($55 million).

TABLE-India's Pfizer Ltd Q2 net profit soars

(versus the same period a year earlier, in million rupees unless stated)

Select another date:

Market Views

» More PFIZ.BO Market Views

Press Releases

view news for: